Esophageal and Gastrointestinal Cancer

  • A. Schauer
  • M. Schauer


Gastric Cancer Sentinel Lymph Node Esophageal Cancer Total Gastrectomy Partial Gastrectomy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abdel-Nabi H, Doerr RJ, Balu D, Rogan L, Farrell EL, Evans NH (1993) Gamma probe assisted ex vivo detection of small lymph node metastases following the administration of indium-111-labeled monoclonal antibodies to colorectal cancers. J Nucl Med 34(10):1818–1822PubMedGoogle Scholar
  2. Abdel-Nabi H, Doerr RJ, Lamonica DM, Cronin VR, Galantowicz PJ, Carbone GM, Spaulding MB (1998) Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 206:755–760PubMedGoogle Scholar
  3. Apel W (1992) c-erb B1, B2 and c-myc-ßberexpression beim Magencarcinom; immunohistochemische Untersuchungen an den Oncogen-codierten Proteinen. Thesis, GöttingenGoogle Scholar
  4. Arnold MW, Schneebaum S, Berens A, Mojzisik C, Hinkle G, Martin EW Jr (1992a) Radioimmunoguided surgery challenges traditional decision making in patients with primary colorectal cancer. Surgery 112(4):624–629, discussion 629–630PubMedGoogle Scholar
  5. Arnold MW, Schneebaum S, Berens A, Petty L, Mojzisik C, Hinkle G, Martin EW Jr (1992b) Intraoperative detection of colorectal cancer with radioimmunoguided surgery and CC49, a second-generation monoclonal antibody. Ann Surg 216(6):627–632PubMedGoogle Scholar
  6. Arnold MW, Hitchcock CL, Young DC, Burak WE Jr, Bertsch DJ, Martin EW Jr (1996) Intra-abdominal patterns of disease dissemination in colorectal cancer identified using radioimmunoguided surgery. Dis Colon Rectum 39(5):509–513CrossRefPubMedGoogle Scholar
  7. Bares R, Klever P, Hauptmann S, Hellwig D, Fass J, Cremerius U, Schumpelick V, Mittermayer C, Bull U (1994) F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 192:79–86PubMedGoogle Scholar
  8. Bilchik AJ, Saha S, Tsioulias GJ, Wood TF, Morton DL (2001a) Aberrant drainage and missed micrometastases: the value of lymphatic mapping and focused analysis of sentinel lymph-nodes in gastrointestinal neoplasms. Ann Surg Oncol 8[Suppl]:82S–85SPubMedGoogle Scholar
  9. Bilchik AJ, Saha S, Wiese D, Stonecypher JA, Wood TF, Sostrin S, Turner RR, Wang HJ, Morton DL, Hoon DS (2001b) Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol 19:1128–1136PubMedGoogle Scholar
  10. Block ML, Patterson GA, Sundaresan RS, Bailey MS, Flanagan FL, Dehdashti F, Siegel BA, Cooper JD (1997) Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg 64:770–776CrossRefPubMedGoogle Scholar
  11. Brücher BL, Weber W, Bauer M, Fink U, Avril N, Stein FH (2001) Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg 233:300–309CrossRefPubMedGoogle Scholar
  12. Burak WE Jr, Schneebaum S, Kim JA, Arnold MW, Hinkle G, Berens A, Mojzisik C, Martin EW Jr (1995) Pilot study evaluating the intraoperative localization of radiolabeled monoclonal antibody CC83 in patients with metastatic colorectal carcinoma. Surgery 118(1):103–108PubMedGoogle Scholar
  13. Choi JY, Lee KH, Shim YM et al (2000) Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET. J Nucl Med 41:808–815PubMedGoogle Scholar
  14. Cohen S, Ushiro H, Stoschek C, Chinkers M (1982) A native 170000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles. J Biol Chem 257:1523–1531PubMedGoogle Scholar
  15. Coussens L, Yang-Feng TL, Liao YC, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schessinger J, Francke U, Levinson A, Ullrich A (1985) Tyrosine kinase receptor with extensive homology to EGF receptor shaves chromosomal location with neu oncogene. Science 230:1132–1139PubMedGoogle Scholar
  16. Curtet C, Vuillez JP, Daniel G, Aillet G, Chetanneau A, Vissed J, Kremer M, Thedrez P, Chatal JF (1990) Feasibility study of radioimmunoguided surgery of colorectal carcinomas using indium-111 CEA-specific monoclonal antibody. Eur J Nucl Med 17(6–8):299–304PubMedGoogle Scholar
  17. David L, Saruca R, Nesland JM, Soares P, Sansonetty F, Hohn R, Borreson AL, Sobrinho-Simões M (1992) C-erb B2 expression in primary gastric carcinomas and their metastases. Mod Pathol 5:384–390PubMedGoogle Scholar
  18. Davidson BR, Waddington WA, Short MD, Boulos PB (1991) Intraoperative localization of colorectal cancers using radiolabelled monoclonal antibodies. Br J Surg 78(6):664–670PubMedGoogle Scholar
  19. Dawson PM, Blair SD, Begent RH, Kelly AM, Boxer GM, Theodorou NA (1991) The value of radioimmunoguided surgery in first and second look laparotomy for colorectal cancer. Dis Colon Rectum 34(3):217–222CrossRefPubMedGoogle Scholar
  20. Di Carlo V, Badellino F, Stella M, De Nardi P, Fazio F, Percivale P, Bertoglio S, Schenone F, Benevento A, Carcano G, Dominioni L, Dionigi R (1994) Role of B72.3 iodine 125-labeled monoclonal antibody in colorectal cancer detection by radioimmunoguided surgery. Surgery 115(2): 190–198PubMedGoogle Scholar
  21. Diederichs CG, Staib L, Glatting G, Beger HG, Reske SN (1998) FDG PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies. J Nucl Med 39:1030–1033PubMedGoogle Scholar
  22. Falck VG, Gullick WJ (1989) C-erb B2-oncogene product staining in gastric adenocarcinoma — an immunohistochemical study. J Pathol 159:107–111CrossRefPubMedGoogle Scholar
  23. Flamen P, Stroobants S, Van Cutsem E, Dupont P, Bormans G, De Vadder N, Penninckx F, Van Hoe L, Mortelmans L (1999) Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer. J Clin Oncol 17:894–901PubMedGoogle Scholar
  24. Flamen P, Lerut A, Van Cutsem E, De Wever W, Peeters M, Stroobants S, Dupont P, Bormans G, Hiele M, De Leyn P, Van Raemdonck D, Coosemans W, Ectors N, Haustermans K, Mortelmans L (2000) Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 18:3202–3210PubMedGoogle Scholar
  25. Flanagan FL, Dehdashti F, Ogunbiyi OA, Kodner IJ, Siegel BA (1998) Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg 227:319–323CrossRefPubMedGoogle Scholar
  26. German Society of Surgery, German Cancer Society (1999) Guidelines. Demeter/Thieme, StuttgartGoogle Scholar
  27. Giuliano AE, Kirgan DM, Guenther JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391–398PubMedGoogle Scholar
  28. Giuliano AE, Kirgan DM, Günther JM, Morton DL (1995) Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222:394–399PubMedGoogle Scholar
  29. Hermanek P, Scheibe O, Spiessl B, Wagner G (2002) TNM-Klassifikation maligner Tumoren. Springer, Berlin Heidelberg, New York for UICC (International Union Against Cancer)Google Scholar
  30. Hoelscher AH, Bollschweiler E, Siewert JR (1995) Carcinoma of the gastric cardia. Ann Chir Gynaecol 84:185–192PubMedGoogle Scholar
  31. Huebner RH, Park KC, Shepherd JE, Schwimmer J, Czernin J, Phelps ME, Gambhic SS (2000) A meta-analysis of the literature for whole-body FDG-PET detection of recurrent colorectal cancer. J Nucl Med 41:1177–1189PubMedGoogle Scholar
  32. Hunter T (1984) The epidermal growth factor gene and its product. Nature 311:414–416CrossRefPubMedGoogle Scholar
  33. Imdahl A, Nitzsche E, Krautmann F, Hogerle S, Boos S, Einert A, Sontheimer J, Farthmann EH (1999) Evaluation of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose for the differentiation of chronic pancreatitis and pancreatic cancer. Br J Surg 86:194–199CrossRefPubMedGoogle Scholar
  34. Jaehne J, Urmacher C, Thaler HT, Friedlander-Klar H, Cordon-Cardo C, Meyer HJ (1992) Expression of her2/neu oncogene product p185 in correlation to clinico pathological and prognostic factors of gastric carcinoma. J Cancer Res Clin Oncol 118:474–479CrossRefPubMedGoogle Scholar
  35. Jain S, Filipe MI, Gullick WJ, Linehan J, Morris RW (1991) c-erb B2, protooncogene expression and its relationship to survival in gastric carcinoma: an immunohistochemical study on archival material. Int J Cancer 48:668–671PubMedGoogle Scholar
  36. Joosten JJ, Strobbe LJ, Wauters CA, Pruszczynski M, Wobbes T, Ruers TJ (1999) Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg 86:482CrossRefPubMedGoogle Scholar
  37. Kodera Y, Yamamura Y, Shimizu Y, Torii A, Hirai T, Yasui K, Morimoto T, Kato T (1999) Adenocarcinoma of the gastroesophageal junction in Japan: relevance of Siewert's classification applied to 177 cases resected at a single institution. J Am Coll Surg 189(6):594–601CrossRefPubMedGoogle Scholar
  38. Kosaka T, Ueshige N, Sugaya J, Nakano Y, Akiyoma T, Tomita F, Saito H, Kita I, Takashima S (1999) Lymphatic routes of the stomachs demonstrated by gastric carcinomas with solitary lymph node metastasis. Surg Today 29:695–700CrossRefPubMedGoogle Scholar
  39. Kuhn JA, Corbisiero RM, Buras RR, Carroll RG, Wagman LD, Wilson LA, Yamauchi D, Smith MM, Kondo R, Beatty JD (1991) Intraoperative gamma detection probe with presurgical antibody imaging in colon cancer. Arch Surg 126(11):1398–1403PubMedGoogle Scholar
  40. Lai DT, Fulham M, Stephen MS, Chu KM, Solomon M, Thompson JF, Sheldon DM, Storey DW (1996) The role of whole-body positron emission tomography with (18F)-fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. Arch Surg 131:703–707PubMedGoogle Scholar
  41. Lechner P, Lind P, Snyder M, Haushofer H (2000) Probeguided surgery for colorectal cancer. Recent Results Cancer Res 157:273–280PubMedGoogle Scholar
  42. Lemoine NR, Jain S, Silvestre F, Lopes C, Hughes MI, McLelland CM, Gullick E, Filipe WJ (1991) Amplification and overexpression of the EGFR and c-erb B2-protooncogenes in human cancer. Br J Cancer 64:79–83PubMedGoogle Scholar
  43. McAteer D, Wallis F, Couper G, Norton M, Welch A, Bruce D, Park K, Nicolson M, Gilbert FJ, Sharp P (1999) Evaluation of 18F-FDG positron emission tomography in gastric and oesophageal carcinoma. Br J Radiol 72(858): 525–529PubMedGoogle Scholar
  44. Meltzer CC, Luketich JD, Friedmann D, Charron M, Strollo D, Meehan M, Urso GK, Dachil MA, Townsend DW (2000) Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography. Clin Nucl Med 25:882–887CrossRefPubMedGoogle Scholar
  45. Merrie AE, Phillips IV, Yun K, McCall JL (1999) The sentinel node in colon cancer. Eur J Nucl Med 26[Suppl]: S263Google Scholar
  46. Merrie AE, Van Rij AM, Phillips LV, Rossaak JI, Yun K, McCall JL (2001) Diagnostic use of the sentinel node in colon cancer. Dis Colon Rectum 44:410–417CrossRefPubMedGoogle Scholar
  47. Minnich T, Marx D, Rothe H, Rehberg S, Hoefer K, Schauer A (1995) Die c-erb B-Familie im Magencarcinom: Korrelation zu anderen prognostischen Faktoren. Verh Dtsch Ges Pathol 79:400Google Scholar
  48. Moffat FL Jr, Vargas-Cuba RD, Serafini AN, Jabir AM, Sfakianakis GN, Sittler SY, Robinson DS, Crichton VZ, Subramanian R, Murray JH, Klein JL, Hanna MG, De Jager RL (1995) Preoperative scintigraphy and operative probe scintimetry of colorectal carcinoma using technetium-99m-88BV59. J Nucl Med 36(5):738–745PubMedGoogle Scholar
  49. Morton DL, Wen DR, Wong JH, Economow JS, Cagle LA, Storm K, Foshag LJ, Cochran AJ (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392–399PubMedGoogle Scholar
  50. Nieweg OE, Tanis PJ, Rutgers EJT (2001) Summary of the Second International Sentinel Node Conference. Eur J Nucl Med 28:646–649CrossRefPubMedGoogle Scholar
  51. Ogunbiyi OA, Flanagan FL, Dehdashti F, Siegel BA, Trask DD, Birnbaum EH, Fleshman JW, Read TE, Philpot GW, Kodner IJ (1997) Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ann Surg Oncol 4:613–620PubMedGoogle Scholar
  52. Ohguri T, Sato Y, Koizumi W, Saigenji K, Kameya T (1993) An immunohistochemical study of c-erb B2 protein in gastric carcinomas and lymph node metastases: Is the c-erb B2 protein really a prognostic indicator? Int J Cancer 53:75–79PubMedGoogle Scholar
  53. Ota DM, Lin K (2001) Lymphatic mapping and sentinel node identification for colorectal cancer. Swiss Surg 7:252–255PubMedGoogle Scholar
  54. Plowman GD, Whitney GS, Neubauer MG, Green JM, McDonald VL, Todaro GJ, Shoyab M (1990) Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc Natl Acad Sci USA 87:4905–4909PubMedGoogle Scholar
  55. Reuter M, Montz R, Heer K de, Schafer H, Klapdor R, Desler K, Schreiber HW (1992) Detection of colorectal carcinomas by intraoperative RIS in addition to preoperative RIS: surgical and immunohistochemical findings. Eur J Nucl Med 19(2):102–129CrossRefPubMedGoogle Scholar
  56. Roh JK, Paik S, Chung HC, Yang W, Kim HK, Choi IJ, Kim J, Koh E, Lee KS, Min JS, Yoon J, Kim BS (1992) Overexpression of erb B2-protein in gastric adenocarcinoma. Gan To Kagaku Ryoho 19(8 Suppl):1207–1219PubMedGoogle Scholar
  57. Saha S, Wiese D, Badin J, Beutler T, Nora D, Ganatra BK, Desai D, Kaushal S, Nagaraju M, Arora M, Singh T (2000) Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging. Ann Surg Oncol 7(2):120–124CrossRefPubMedGoogle Scholar
  58. Sendler A, Avril N, Helmberger H, Stollfuss J, Weber W, Bengel F, Schwaiger M, Roder JD, Siewert JR (2000) Preoperative evaluation of pancreatic masses with positron emission tomography using 18F-fluorodeoxyglucose: diagnostic limitations. World J Surg 24:1121–1129PubMedGoogle Scholar
  59. Shreve PD (1998) Focal fluorine-18 fluorodeoxyglucose accumulation in inflammatory pancreatic disease. Eur J Nucl Med 25:259–264CrossRefPubMedGoogle Scholar
  60. Siewert JR, Lange J (1990) Lymphadenektomie bei Magen-und kolorektalem Karcinom. Dtsch Med Wochenschr 115:391–394PubMedGoogle Scholar
  61. Siewert JR, Stein JH (1998) Classification of adenocarcinoma of the eosophagogastric junction. Br J Surg 85:1457–1459CrossRefPubMedGoogle Scholar
  62. Siewert JR, Lange J, Bottcher K, Becker K, Stier A (1986) Lymphadenektomie beim Magencarcinom. Langenbeck's Arch 368:137–148CrossRefGoogle Scholar
  63. Siewert JR, Hoelscher AH, Becker K, Goessner W (1987) Cardia cancer: attempt at a therapeutically relevant classification. Chirurg 58:25–32PubMedGoogle Scholar
  64. Siewert JR, Böttcher K, Stein HJ, Roder JD, Busch R (1995) Problem of proximal third gastric carcinoma. World J Surg 19(4):523–531PubMedGoogle Scholar
  65. Siewert JR, Stein JH, Sendler A, Fink U (1999) Surgical resection for cancer of the cardia. Semin Surg Oncol 17:125–131CrossRefPubMedGoogle Scholar
  66. Siewert JR, Feith M, Werner M, Stein HJ (2000) Adenocarcinoma of the esophagogastric junction. Results of surgical therapy based on the anatomical topographic classification in 1002 consecutive patients. Ann Surg 282:353–361Google Scholar
  67. Spiessl B, Beahrs OH, Hermanek P, Hiitter RVP, Scheibe O, Sobin LH, Wagner G (eds) (1990/1993) TNM atlas. Springer, Berlin Heidelberg New YorkGoogle Scholar
  68. Spürr NK, Solomon E, Jansson M, Scheer D, Goodfellow PN, Bodmer WF, Vennstrom B (1984) Chromosomal localisation of the human homologues to the oncogene erb A and B. EMBO J 3:159–163PubMedGoogle Scholar
  69. Stein JH, Feith M, Siewert JR (2000) Cancer of the esophagogastric junction. Surg Oncol 9:35–41CrossRefPubMedGoogle Scholar
  70. Stella M, De Nardi P, Paganelli G, Magnani P, Mangili F, Sassi I, Baratti D, Gini P, Zito F, Cristallo M, Facio F, DiCarlo V (1994) Avidin-biotin system in radioimmunoguided surgery for colorectal cancer. Advantages and limits. Dis Colon Rectum 37(4):335–343CrossRefPubMedGoogle Scholar
  71. Stollfuss JC, Glatting G, Friess H, Kocher F, Berger HG, Reske SN (1995) 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation. Radiology 195:339–344PubMedGoogle Scholar
  72. Sugiyama K, Yonemura Y, Miyazaki I (1989) Immunohistochemical study of epidermal growth factor and epidermal growth factor receptor in gastric carcinoma. Cancer 63:1557–1561PubMedGoogle Scholar
  73. Terui S, Kato H, Hirashima T, Lizuka T, Oyamada H (1982) An evaluation of the mediastinal lymphoscintigram for carcinoma of the esophagus studied with 99mTc rhenium sulfur colloid. Eur J Nucl Med 7:99–101CrossRefPubMedGoogle Scholar
  74. Triboulet JP, Fabre S, Castel B, Toursel H (2001) Adenocarcinomas of the distal esophagus and cardia: surgical management. Cancer Radiother 5[Suppl1]:90s–97sPubMedGoogle Scholar
  75. Tsioulias GJ, Wood TF, Morton DL, Bilchik AJ (2000) Lymphatic mapping and focused analysis of sentinel lymph-nodes upstage gastrointestinal neoplasms. Arch Surg 135(8):926–932CrossRefPubMedGoogle Scholar
  76. Vitola JV, Delbeke D, Sandier MP, Campbell MG, Powers TA, Wright JK, Chapman WC, Pinson CW (1996) Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 171:21–26CrossRefPubMedGoogle Scholar
  77. Waddington WA, Davidson BR, Todd-Pokropek A, Boulos PB, Short MD (1991) Evaluation of a technique for the intraoperative detection of a radiolabelled monoclonal antibody against colorectal cancer. Eur J Nucl Med 18(12):964–972CrossRefPubMedGoogle Scholar
  78. Waters GS, Geisinger KR, Garske DD, Loggie BW, Levine EA (2000) Sentinel lymph node mapping for carcinoma of the colon: a pilot study. Am Surg 66:943–945PubMedGoogle Scholar
  79. Wiese DA, Saha S, Badin J (1999) Sentinel node mapping in staging of colorectal carcinoma. Am J Clin Pathol 112:542Google Scholar
  80. Wong JH, Steineman S, Calderia C, Bowles J, Namiki T (2002) Ex vivo sentinel node mapping in carcinoma of the colon and rectum. Ann Surg 233:515–521CrossRefGoogle Scholar
  81. Yamamoto Y, Takahashi K, Yasuno M, Sakoma T, Mori T (1998) Clinicopathological characteristics of skipping lymph node metastases in patients with colorectal cancer. Jpn J Clin Oncol 28:378–382CrossRefPubMedGoogle Scholar
  82. Yanagi M, Keller G, Mueller J, Walch A, Werner M, Stein JH, Siewert JR, Höfler H (2000) Comparison of loss of heterozygosity and microsatellite instability in adenocarcinomas of the distal esophagus and proximal stomach. Virchows Arch 437:605–610CrossRefPubMedGoogle Scholar
  83. Yonemura Y, Ninomiya I, Yamaguchi A, Fushida S, Kimura H, Ohoyama S, Miyazaki I, Endou Y, Tanaka M, Sasaki T (1991) Evaluation of immunoreactivity of erb B2 protein as a marker of poor short term prognosis in gastric cancer. Cancer Res 51:1034–1038PubMedGoogle Scholar
  84. Yonemura Y, Ninomiya I, Ohoyama S, Fushida S, Kimura H, Tsugawa K, Kamata T, Yamaguchi A, Miyazaki I, Endou Y, Tanaka M, Sasaki T (1992) Correlation of c-erb B2 protein and lymph node status in early gastric cancer. Oncology 49:363–367PubMedGoogle Scholar
  85. Zimny M, Fass J, Bares R, Cremerius U, Sabrio, Buechin P, Schumpelick V, Bull U (2000) Fluorodeoxyglucose positron emission tomography and the prognosis of pancreatic carcinoma. Scand J Gastroenterol 35:883–888CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • A. Schauer
  • M. Schauer

There are no affiliations available

Personalised recommendations